Literature DB >> 18512708

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis.

Kenneth G Saag1, Gim Gee Teng, Nivedita M Patkar, Jeremy Anuntiyo, Catherine Finney, Jeffrey R Curtis, Harold E Paulus, Amy Mudano, Maria Pisu, Mary Elkins-Melton, Ryan Outman, Jeroan J Allison, Maria Suarez Almazor, S Louis Bridges, W Winn Chatham, Marc Hochberg, Catherine MacLean, Ted Mikuls, Larry W Moreland, James O'Dell, Anthony M Turkiewicz, Daniel E Furst.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18512708     DOI： 10.1002/art.23721

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  399 in total

1.  Patient-physician discordance in assessments of global disease severity in rheumatoid arthritis.

Authors:  Jennifer L Barton; John Imboden; Jonathan Graf; David Glidden; Edward H Yelin; Dean Schillinger
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-06       Impact factor: 4.794

2.  Cost effectiveness of interferon-gamma release assay for tuberculosis screening of rheumatoid arthritis patients prior to initiation of tumor necrosis factor-α antagonist therapy.

Authors:  Akiko Kowada
Journal:  Mol Diagn Ther       Date:  2010-12-01       Impact factor: 4.074

3.  Chronic noninfectious uveitis associated with Vogt-Koyanagi-Harada disease treated with low-dose weekly systemic methotrexate.

Authors:  Yukiko Kondo; Ken Fukuda; Katsuyoshi Suzuki; Teruo Nishida
Journal:  Jpn J Ophthalmol       Date:  2011-10-26       Impact factor: 2.447

4.  A rich pipeline that needs to be managed.

Authors:  Keith Bradbury
Journal:  Biotechnol Healthc       Date:  2009-10

Review 5.  Safety of biologic therapy in rheumatoid arthritis.

Authors:  Robert S Woodrick; Eric M Ruderman
Journal:  Nat Rev Rheumatol       Date:  2011-10-11       Impact factor: 20.543

Review 6.  My treatment approach to rheumatoid arthritis.

Authors:  John M Davis; Eric L Matteson
Journal:  Mayo Clin Proc       Date:  2012-07       Impact factor: 7.616

7.  Rheumatoid arthritis: Guidelines for RA therapy-avoiding hamartia.

Authors:  Arthur Kavanaugh
Journal:  Nat Rev Rheumatol       Date:  2010-09       Impact factor: 20.543

8.  Successes achieved and challenges ahead in translating biomarkers into clinical applications.

Authors:  Greg Tesch; Shashi Amur; John T Schousboe; Jeffrey N Siegel; Lawrence J Lesko; Jane P F Bai
Journal:  AAPS J       Date:  2010-03-16       Impact factor: 4.009

Review 9.  [Infectious complications of biologic therapy in patients with rheumatoid arthritis].

Authors:  D Meyer-Olson; K Hoeper; R E Schmidt
Journal:  Z Rheumatol       Date:  2010-12       Impact factor: 1.372

10.  Prescribing practices in a US cohort of rheumatoid arthritis patients before and after publication of the American College of Rheumatology treatment recommendations.

Authors:  Leslie R Harrold; J Timothy Harrington; Jeffrey R Curtis; Daniel E Furst; Mary Jane Bentley; Ying Shan; George Reed; Joel Kremer; Jeffrey D Greenberg
Journal:  Arthritis Rheum       Date:  2012-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.